DISCOUNT ZERTIFIKAT - MEDTRONIC Stock

Certificat

DE000PN6ANK4

Delayed Deutsche Boerse AG 11:20:23 2024-05-24 EDT
73.03 EUR -0.22% Intraday chart for DISCOUNT ZERTIFIKAT - MEDTRONIC
Current month+0.74%
1 month+0.72%
Date Price Change
24-05-24 73.03 -0.22%
24-05-23 73.19 -0.14%
24-05-22 73.29 +0.40%
24-05-21 73 +0.16%
24-05-20 72.88 +0.03%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 11:20 am

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN6ANK
ISINDE000PN6ANK4
Date issued 2023-07-25
Maturity 2024-06-21 (28 Days)
Parity 1 : 1
Emission price 65.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 73.45
Lowest since issue 61.93
Spread 0.1
Spread %0.14%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.38 USD
Average target price
94.74 USD
Spread / Average Target
+16.41%
Consensus